Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;164(2):314-322.
doi: 10.1016/j.chest.2023.02.048. Epub 2023 Mar 7.

CT Scan-Derived Muscle, But Not Fat, Area Independently Predicts Mortality in COVID-19

Affiliations

CT Scan-Derived Muscle, But Not Fat, Area Independently Predicts Mortality in COVID-19

Sophie I J van Bakel et al. Chest. 2023 Aug.

Abstract

Background: COVID-19 has demonstrated a highly variable disease course, from asymptomatic to severe illness and eventually death. Clinical parameters, as included in the 4C Mortality Score, can predict mortality accurately in COVID-19. Additionally, CT scan-derived low muscle and high adipose tissue cross-sectional areas (CSAs) have been associated with adverse outcomes in COVID-19.

Research question: Are CT scan-derived muscle and adipose tissue CSAs associated with 30-day in-hospital mortality in COVID-19, independent of 4C Mortality Score?

Study design and methods: This was a retrospective cohort analysis of patients with COVID-19 seeking treatment at the ED of two participating hospitals during the first wave of the pandemic. Skeletal muscle and adipose tissue CSAs were collected from routine chest CT-scans at admission. Pectoralis muscle CSA was demarcated manually at the fourth thoracic vertebra, and skeletal muscle and adipose tissue CSA was demarcated at the first lumbar vertebra level. Outcome measures and 4C Mortality Score items were retrieved from medical records.

Results: Data from 578 patients were analyzed (64.6% men; mean age, 67.7 ± 13.5 years; 18.2% 30-day in-hospital mortality). Patients who died within 30 days demonstrated lower pectoralis CSA (median, 32.6 [interquartile range (IQR), 24.3-38.8] vs 35.4 [IQR, 27.2-44.2]; P = .002) than survivors, whereas visceral adipose tissue CSA was higher (median, 151.1 [IQR, 93.6-219.7] vs 112.9 [IQR, 63.7-174.1]; P = .013). In multivariate analyses, low pectoralis muscle CSA remained associated with 30-day in-hospital mortality when adjusted for 4C Mortality Score (hazard ratio, 0.98; 95% CI, 0.96-1.00; P = .038).

Interpretation: CT scan-derived low pectoralis muscle CSA is associated significantly with higher 30-day in-hospital mortality in patients with COVID-19 independently of the 4C Mortality Score.

Keywords: COVID-19; CT scan; body composition; mortality; skeletal muscle.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1
Figure 1
A-D, Representative examples of selected CT scan slices at the fourth thoracic vertebra level (A) with demarcated pectoralis major and minor muscle (B) and at first lumbar vertebra (L1) level (C) with demarcated L1 muscle, visceral, and subcutaneous adipose tissue (D).
Figure 2
Figure 2
Flow chart showing available CT scan images and tissues of interest. If a selected image was of poor quality, had artefacts, or tissue of interest was not depicted fully, the specific slice or missing tissue was considered as a missing value. L1 = first lumbar vertebra; MUMC+ = Maastricht University Medical Centre+; SAT = subcutaneous adipose tissue; VAT = visceral adipose tissue.

Comment in

References

    1. Chen S., Sun H., Heng M., et al. Factors predicting progression to severe COVID-19: a competing risk survival analysis of 1753 patients in community isolation in Wuhan, China. Engineering (Beijing) 2022;13:99–106. - PMC - PubMed
    1. Adjei S., Hong K., Molinari N.M., et al. Mortality risk among patients hospitalized primarily for COVID-19 during the omicron and delta variant pandemic periods—United States, April 2020-June 2022. MMWR Morb Mortal Wkly Rep. 2022;71(37):1182–1189. - PMC - PubMed
    1. Nijman G., Wientjes M., Ramjith J., et al. Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: a competing risk survival analysis. PLoS One. 2021;16(3) - PMC - PubMed
    1. Giorgi Rossi P., Marino M., Formisano D., et al. Characteristics and outcomes of a cohort of COVID-19 patients in the province of Reggio Emilia, Italy. PLoS One. 2020;15(8) - PMC - PubMed
    1. Simpson S., Kay F.U., Abbara S., et al. Radiological Society of North America Expert Consensus Statement on reporting chest CT findings related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA—Secondary Publication. J Thorac Imaging. 2020;35(4):219–227. - PMC - PubMed

Publication types